Cannara Biotech reports record FY2024 revenue of $82.2M (+43%), strong Q4 growth, 3.2% national market share, and plans for expanded production.
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- SYM COURT UPDATE: The Symbotic Inc. Class Action Deadline is February 3 –Investors with Losses are Urged to Contact BFA Law (NASDAQ:SYM) - December 8, 2024
- Caribbean Airlines Brings the Region Closerwith New Service to Guadeloupe - December 7, 2024
- Pennsylvania Skill, powered by Pace-O-Matic, Responds to Commonwealth Court Ruling in Favor of Skill Games - December 7, 2024
